For example, liposomal nanoparticles complexed with a PD-L1 trap plasmid and cationic protamine to form lipid-protamine-DNA (LPD) nanoparticles have been tested as a method for targeting tumor tissue using aminoethyl anisamide ligands [43]. This evidence concerns the gene CD274 and neoplasm.